Selected research
Market Structure
Global DHA and EPA Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global DHA and EPA Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for DHA and EPA Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for DHA and EPA Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for DHA and EPA Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for DHA and EPA Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of DHA and EPA Products include BASF SE, Neptune Wellness Solutions, The Archer Daniels Midland Company, Omega Protein Corporation, Golden Omega, GC Reiber, DSM, Croda International PLC and Corbion NV, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global DHA and EPA Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of DHA and EPA Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents DHA and EPA Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DHA and EPA Products market size, projected growth trends, production technologies, key applications, and end-use industries.
DHA and EPA Products Segment by Company
BASF SE
Neptune Wellness Solutions
The Archer Daniels Midland Company
Omega Protein Corporation
Golden Omega
GC Reiber
DSM
Croda International PLC
Corbion NV
Clover Corporation Ltd
DHA and EPA Products Segment by Type
Triglycerides
Ethyl Esters
DHA and EPA Products Segment by Application
Infant Formulae
Pharmaceuticals
Dietary Supplements
Fortified Food and Beverages
Other Applications
DHA and EPA Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DHA and EPA Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DHA and EPA Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DHA and EPA Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the DHA and EPA Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DHA and EPA Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of DHA and EPA Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of DHA and EPA Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Triglycerides
- Ethyl Esters
Applications
- Infant Formulae
- Pharmaceuticals
- Dietary Supplements
- Fortified Food and Beverages
- Other Applications
Companies covered
- BASF SE
- Neptune Wellness Solutions
- The Archer Daniels Midland Company
- Omega Protein Corporation
- Golden Omega
- GC Reiber
- DSM
- Croda International PLC
- Corbion NV
- Clover Corporation Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global DHA and EPA Products Market Size, 2021 VS 2025 VS 2032
- 1.3 Global DHA and EPA Products Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global DHA and EPA Products Sales Estimates and Forecasts (2021-2032)
- 1.5 Global DHA and EPA Products Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global DHA and EPA Products Market Dynamics
- 2.1 DHA and EPA Products Industry Trends
- 2.2 DHA and EPA Products Industry Drivers
- 2.3 DHA and EPA Products Industry Opportunities and Challenges
- 2.4 DHA and EPA Products Industry Restraints
3 DHA and EPA Products Market by Manufacturers
- 3.1 Global DHA and EPA Products Revenue by Manufacturers (2021-2026)
- 3.2 Global DHA and EPA Products Sales by Manufacturers (2021-2026)
- 3.3 Global DHA and EPA Products Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global DHA and EPA Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global DHA and EPA Products Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global DHA and EPA Products Manufacturers, Product Type & Application
- 3.7 Global DHA and EPA Products Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global DHA and EPA Products Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 DHA and EPA Products Players Market Share by Revenue in 2025
- 3.8.3 2025 DHA and EPA Products Tier 1, Tier 2, and Tier 3
4 DHA and EPA Products Market by Type
- 4.1 DHA and EPA Products Type Introduction
- 4.1.1 Triglycerides
- 4.1.2 Ethyl Esters
- 4.2 Global DHA and EPA Products Sales by Type
- 4.2.1 Global DHA and EPA Products Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global DHA and EPA Products Sales by Type (2021-2032)
- 4.2.3 Global DHA and EPA Products Sales Market Share by Type (2021-2032)
- 4.3 Global DHA and EPA Products Revenue by Type
- 4.3.1 Global DHA and EPA Products Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global DHA and EPA Products Revenue by Type (2021-2032)
- 4.3.3 Global DHA and EPA Products Revenue Market Share by Type (2021-2032)
5 DHA and EPA Products Market by Application
- 5.1 DHA and EPA Products Application Introduction
- 5.1.1 Infant Formulae
- 5.1.2 Pharmaceuticals
- 5.1.3 Dietary Supplements
- 5.1.4 Fortified Food and Beverages
- 5.1.5 Other Applications
- 5.2 Global DHA and EPA Products Sales by Application
- 5.2.1 Global DHA and EPA Products Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global DHA and EPA Products Sales by Application (2021-2032)
- 5.2.3 Global DHA and EPA Products Sales Market Share by Application (2021-2032)
- 5.3 Global DHA and EPA Products Revenue by Application
- 5.3.1 Global DHA and EPA Products Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global DHA and EPA Products Revenue by Application (2021-2032)
- 5.3.3 Global DHA and EPA Products Revenue Market Share by Application (2021-2032)
6 Global DHA and EPA Products Sales by Region
- 6.1 Global DHA and EPA Products Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global DHA and EPA Products Sales by Region (2021-2032)
- 6.2.1 Global DHA and EPA Products Sales by Region (2021-2026)
- 6.2.2 Global DHA and EPA Products Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America DHA and EPA Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America DHA and EPA Products Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe DHA and EPA Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe DHA and EPA Products Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific DHA and EPA Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific DHA and EPA Products Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa DHA and EPA Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa DHA and EPA Products Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global DHA and EPA Products Revenue by Region
- 7.1 Global DHA and EPA Products Revenue by Region
- 7.1.1 Global DHA and EPA Products Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global DHA and EPA Products Revenue by Region (2021-2026)
- 7.1.3 Global DHA and EPA Products Revenue by Region (2027-2032)
- 7.1.4 Global DHA and EPA Products Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America DHA and EPA Products Revenue (2021-2032)
- 7.2.2 North America DHA and EPA Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe DHA and EPA Products Revenue (2021-2032)
- 7.3.2 Europe DHA and EPA Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific DHA and EPA Products Revenue (2021-2032)
- 7.4.2 Asia-Pacific DHA and EPA Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa DHA and EPA Products Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa DHA and EPA Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 BASF SE
- 8.1.1 BASF SE Company Information
- 8.1.2 BASF SE Business Overview
- 8.1.3 BASF SE DHA and EPA Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 BASF SE DHA and EPA Products Product Portfolio
- 8.1.5 BASF SE Recent Developments
- 8.2 Neptune Wellness Solutions
- 8.2.1 Neptune Wellness Solutions Company Information
- 8.2.2 Neptune Wellness Solutions Business Overview
- 8.2.3 Neptune Wellness Solutions DHA and EPA Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Neptune Wellness Solutions DHA and EPA Products Product Portfolio
- 8.2.5 Neptune Wellness Solutions Recent Developments
- 8.3 The Archer Daniels Midland Company
- 8.3.1 The Archer Daniels Midland Company Company Information
- 8.3.2 The Archer Daniels Midland Company Business Overview
- 8.3.3 The Archer Daniels Midland Company DHA and EPA Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 The Archer Daniels Midland Company DHA and EPA Products Product Portfolio
- 8.3.5 The Archer Daniels Midland Company Recent Developments
- 8.4 Omega Protein Corporation
- 8.4.1 Omega Protein Corporation Company Information
- 8.4.2 Omega Protein Corporation Business Overview
- 8.4.3 Omega Protein Corporation DHA and EPA Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Omega Protein Corporation DHA and EPA Products Product Portfolio
- 8.4.5 Omega Protein Corporation Recent Developments
- 8.5 Golden Omega
- 8.5.1 Golden Omega Company Information
- 8.5.2 Golden Omega Business Overview
- 8.5.3 Golden Omega DHA and EPA Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Golden Omega DHA and EPA Products Product Portfolio
- 8.5.5 Golden Omega Recent Developments
- 8.6 GC Reiber
- 8.6.1 GC Reiber Company Information
- 8.6.2 GC Reiber Business Overview
- 8.6.3 GC Reiber DHA and EPA Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 GC Reiber DHA and EPA Products Product Portfolio
- 8.6.5 GC Reiber Recent Developments
- 8.7 DSM
- 8.7.1 DSM Company Information
- 8.7.2 DSM Business Overview
- 8.7.3 DSM DHA and EPA Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 DSM DHA and EPA Products Product Portfolio
- 8.7.5 DSM Recent Developments
- 8.8 Croda International PLC
- 8.8.1 Croda International PLC Company Information
- 8.8.2 Croda International PLC Business Overview
- 8.8.3 Croda International PLC DHA and EPA Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Croda International PLC DHA and EPA Products Product Portfolio
- 8.8.5 Croda International PLC Recent Developments
- 8.9 Corbion NV
- 8.9.1 Corbion NV Company Information
- 8.9.2 Corbion NV Business Overview
- 8.9.3 Corbion NV DHA and EPA Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Corbion NV DHA and EPA Products Product Portfolio
- 8.9.5 Corbion NV Recent Developments
- 8.10 Clover Corporation Ltd
- 8.10.1 Clover Corporation Ltd Company Information
- 8.10.2 Clover Corporation Ltd Business Overview
- 8.10.3 Clover Corporation Ltd DHA and EPA Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Clover Corporation Ltd DHA and EPA Products Product Portfolio
- 8.10.5 Clover Corporation Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 DHA and EPA Products Value Chain Analysis
- 9.1.1 DHA and EPA Products Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 DHA and EPA Products Production Mode & Process
- 9.2 DHA and EPA Products Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 DHA and EPA Products Distributors
- 9.2.3 DHA and EPA Products Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst